These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37955647)

  • 1. The impact of submandibular glands protection on xerostomia as monitored by diffusion-weighted imaging in nasopharyngeal carcinoma patients.
    Zhao D; Fan W; Jiang H; Meng L; Cai B; Zhang X; Yu W; Zhao L; Ma L
    Strahlenther Onkol; 2024 May; 200(5):377-388. PubMed ID: 37955647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparing submandibular gland to alleviating acute xerostomia in patients with nasopharyngeal carcinoma treated with helical tomotherapy: Evaluation by diffusion kurtosis imaging.
    Zhao DW; Fan WJ; Fang XM; Luo YR; Wei J; Chen NX; Zhang XX; Liu G; Li JF; Zang X; Li M; Meng L; Ma L
    Radiother Oncol; 2022 Jul; 172():91-98. PubMed ID: 35584742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted imaging as a follow-up modality for evaluation of major salivary gland function in nasopharyngeal carcinoma patients: a preliminary study.
    Fan WJ; Teng F; Luo YR; Yu W; Zhang Q; Lu YP; Ma L
    Strahlenther Onkol; 2020 Jun; 196(6):530-541. PubMed ID: 32025803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy.
    Zhao DW; Fang XM; Zhou SH; Luo YR; Wei J; Liu K; Meng LL; Liu G; Li JF; Zang X; Li M; Qiang XF; Jiang HY; Fan WJ; Zhang XX; Ma L
    Front Oncol; 2022; 12():870315. PubMed ID: 35664750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion weighted imaging in submandibular gland sparing helical tomotherapy for nasopharyngeal carcinoma.
    Fan WJ; Teng F; Liu G; Zhao DW; Li JF; Luo YR; Zhang XX; Ma L; Guan J
    Radiother Oncol; 2021 Apr; 157():247-254. PubMed ID: 33587972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Salivary Gland Function Using Diffusion-Weighted Magnetic Resonance Imaging for Follow-Up of Radiation-Induced Xerostomia.
    Zhang Y; Ou D; Gu Y; He X; Peng W
    Korean J Radiol; 2018; 19(4):758-766. PubMed ID: 29962882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up.
    Sim C; Soong YL; Pang E; Lim C; Walker GD; Manton DJ; Reynolds EC; Wee J
    Aust Dent J; 2018 Jun; 63(2):217-223. PubMed ID: 29569726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging to evaluate major salivary gland function before and after radiotherapy.
    Dirix P; De Keyzer F; Vandecaveye V; Stroobants S; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1365-71. PubMed ID: 18355977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early evaluation of irradiated parotid glands with intravoxel incoherent motion MR imaging: correlation with dynamic contrast-enhanced MR imaging.
    Zhou N; Chu C; Dou X; Li M; Liu S; Zhu L; Liu B; Guo T; Chen W; He J; Yan J; Zhou Z; Yang X; Liu T
    BMC Cancer; 2016 Nov; 16(1):865. PubMed ID: 27821130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observation of submandibular gland transfer for the prevention of xerostomia after radiotherapy for nasopharyngeal carcinoma: a prospective randomized controlled study of 32 cases.
    Zhang X; Liu F; Lan X; Yu L; Wu W; Wu X; Xiao F; Li S
    Radiat Oncol; 2014 Feb; 9():62. PubMed ID: 24555575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact on xerostomia for nasopharyngeal carcinoma patients treated with superficial parotid lobe-sparing intensity-modulated radiation therapy (SPLS-IMRT): A prospective phase II randomized controlled study.
    Huang H; Miao J; Xiao X; Hu J; Zhang G; Peng Y; Lu S; Liang Y; Huang S; Han F; Deng X; Zhao C; Wang L
    Radiother Oncol; 2022 Oct; 175():1-9. PubMed ID: 35817320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Changes in Apparent Diffusion Coefficient for Salivary Glands during Radiotherapy for Nasopharyngeal Carcinoma Associated with Xerostomia.
    Zhang Q; Wei YM; Qi YG; Li BS
    Korean J Radiol; 2018; 19(2):328-333. PubMed ID: 29520191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life.
    Hawkins PG; Lee JY; Mao Y; Li P; Green M; Worden FP; Swiecicki PL; Mierzwa ML; Spector ME; Schipper MJ; Eisbruch A
    Radiother Oncol; 2018 Jan; 126(1):68-74. PubMed ID: 28823405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
    Eisbruch A; Kim HM; Terrell JE; Marsh LH; Dawson LA; Ship JA
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):695-704. PubMed ID: 11395238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced Xerostomia is Related to Stem Cell Dose-dependent Reduction of Saliva Production.
    van Rijn-Dekker MI; la Bastide-van Gemert S; Stokman MA; Vissink A; Coppes RP; Langendijk JA; van Luijk P; Steenbakkers RJHM
    Int J Radiat Oncol Biol Phys; 2024 Nov; 120(3):772-782. PubMed ID: 38631537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential predictive value of IVIM MR for xerostomia in nasopharyngeal carcinoma.
    Shen M; Lin X; Yang C; Zhou Z; Chen S; Yin Y; Long L; Huang L; Yang Z; Wang R; Kang M
    Radiother Oncol; 2024 Aug; 197():110323. PubMed ID: 38734144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
    Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
    PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.